Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0031248 | protein acetyltransferase complex | 3 | 1 |
GO:0031414 | N-terminal protein acetyltransferase complex | 4 | 1 |
GO:0031416 | NatB complex | 5 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140535 | intracellular protein-containing complex | 2 | 1 |
GO:1902493 | acetyltransferase complex | 4 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1990234 | transferase complex | 3 | 1 |
Related structures:
AlphaFold database: E9AXY0
Term | Name | Level | Count |
---|---|---|---|
GO:0006473 | protein acetylation | 6 | 1 |
GO:0006474 | N-terminal protein amino acid acetylation | 5 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 6 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018206 | peptidyl-methionine modification | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0031365 | N-terminal protein amino acid modification | 5 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043543 | protein acylation | 5 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0051604 | protein maturation | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016407 | acetyltransferase activity | 5 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016746 | acyltransferase activity | 3 | 11 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 11 |
GO:0004596 | peptide alpha-N-acetyltransferase activity | 8 | 1 |
GO:0008080 | N-acetyltransferase activity | 6 | 1 |
GO:0016410 | N-acyltransferase activity | 5 | 1 |
GO:0034212 | peptide N-acetyltransferase activity | 7 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 136 | 138 | PF00675 | 0.308 |
CLV_NRD_NRD_1 | 165 | 167 | PF00675 | 0.402 |
CLV_NRD_NRD_1 | 214 | 216 | PF00675 | 0.408 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.449 |
CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.487 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.308 |
CLV_PCSK_KEX2_1 | 214 | 216 | PF00082 | 0.522 |
CLV_PCSK_KEX2_1 | 219 | 221 | PF00082 | 0.525 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.486 |
CLV_PCSK_PC7_1 | 210 | 216 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 137 | 141 | PF00082 | 0.420 |
CLV_PCSK_SKI1_1 | 185 | 189 | PF00082 | 0.353 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.488 |
CLV_PCSK_SKI1_1 | 229 | 233 | PF00082 | 0.450 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.396 |
DOC_CYCLIN_RxL_1 | 42 | 53 | PF00134 | 0.373 |
DOC_CYCLIN_yCln2_LP_2 | 227 | 233 | PF00134 | 0.438 |
DOC_MAPK_gen_1 | 217 | 227 | PF00069 | 0.435 |
DOC_PP2B_LxvP_1 | 14 | 17 | PF13499 | 0.490 |
DOC_PP2B_LxvP_1 | 48 | 51 | PF13499 | 0.367 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.387 |
DOC_USP7_MATH_1 | 149 | 153 | PF00917 | 0.420 |
DOC_USP7_MATH_1 | 199 | 203 | PF00917 | 0.539 |
DOC_USP7_UBL2_3 | 217 | 221 | PF12436 | 0.483 |
LIG_14-3-3_CanoR_1 | 219 | 225 | PF00244 | 0.439 |
LIG_14-3-3_CanoR_1 | 58 | 63 | PF00244 | 0.443 |
LIG_AP2alpha_1 | 160 | 164 | PF02296 | 0.308 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.409 |
LIG_FHA_1 | 141 | 147 | PF00498 | 0.323 |
LIG_FHA_2 | 59 | 65 | PF00498 | 0.384 |
LIG_Integrin_RGD_1 | 192 | 194 | PF01839 | 0.329 |
LIG_LIR_Gen_1 | 157 | 165 | PF02991 | 0.387 |
LIG_LIR_Gen_1 | 174 | 184 | PF02991 | 0.342 |
LIG_LIR_Gen_1 | 65 | 76 | PF02991 | 0.442 |
LIG_LIR_Gen_1 | 94 | 102 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 134 | 138 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 157 | 163 | PF02991 | 0.289 |
LIG_LIR_Nem_3 | 174 | 179 | PF02991 | 0.298 |
LIG_LIR_Nem_3 | 65 | 71 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.381 |
LIG_LIR_Nem_3 | 90 | 95 | PF02991 | 0.358 |
LIG_PDZ_Class_3 | 234 | 239 | PF00595 | 0.596 |
LIG_PDZ_Wminus1_1 | 237 | 239 | PF00595 | 0.634 |
LIG_Pex14_1 | 5 | 9 | PF04695 | 0.394 |
LIG_Pex14_2 | 160 | 164 | PF04695 | 0.299 |
LIG_SH2_CRK | 176 | 180 | PF00017 | 0.308 |
LIG_SH2_CRK | 184 | 188 | PF00017 | 0.351 |
LIG_SH2_STAT5 | 110 | 113 | PF00017 | 0.359 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.303 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.327 |
LIG_SH2_STAT5 | 88 | 91 | PF00017 | 0.372 |
LIG_SH3_2 | 196 | 201 | PF14604 | 0.595 |
LIG_SH3_3 | 193 | 199 | PF00018 | 0.584 |
LIG_SH3_3 | 227 | 233 | PF00018 | 0.421 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.448 |
LIG_SUMO_SIM_par_1 | 142 | 147 | PF11976 | 0.397 |
LIG_TYR_ITIM | 182 | 187 | PF00017 | 0.351 |
LIG_WW_3 | 1 | 5 | PF00397 | 0.401 |
MOD_CK1_1 | 127 | 133 | PF00069 | 0.308 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.308 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.299 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.481 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.411 |
MOD_N-GLC_1 | 80 | 85 | PF02516 | 0.500 |
MOD_NEK2_1 | 108 | 113 | PF00069 | 0.357 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.314 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.497 |
MOD_NEK2_1 | 76 | 81 | PF00069 | 0.388 |
MOD_NEK2_2 | 80 | 85 | PF00069 | 0.451 |
MOD_PK_1 | 220 | 226 | PF00069 | 0.500 |
MOD_PKA_1 | 219 | 225 | PF00069 | 0.493 |
MOD_PKA_1 | 58 | 64 | PF00069 | 0.417 |
MOD_PKA_2 | 165 | 171 | PF00069 | 0.323 |
MOD_PKA_2 | 219 | 225 | PF00069 | 0.484 |
MOD_PKA_2 | 58 | 64 | PF00069 | 0.472 |
MOD_Plk_1 | 80 | 86 | PF00069 | 0.495 |
MOD_Plk_4 | 140 | 146 | PF00069 | 0.359 |
MOD_Plk_4 | 220 | 226 | PF00069 | 0.446 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.428 |
MOD_SUMO_for_1 | 231 | 234 | PF00179 | 0.455 |
TRG_ENDOCYTIC_2 | 176 | 179 | PF00928 | 0.308 |
TRG_ENDOCYTIC_2 | 184 | 187 | PF00928 | 0.334 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.401 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.354 |
TRG_ER_diArg_1 | 135 | 137 | PF00400 | 0.308 |
TRG_ER_diArg_1 | 213 | 215 | PF00400 | 0.472 |
TRG_ER_diArg_1 | 57 | 59 | PF00400 | 0.504 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I212 | Leptomonas seymouri | 91% | 100% |
A0A0S4JB69 | Bodo saltans | 28% | 84% |
A0A0S4KNL4 | Bodo saltans | 63% | 100% |
A0A1X0NYV1 | Trypanosomatidae | 77% | 100% |
A0A3Q8ID89 | Leishmania donovani | 98% | 100% |
A0A422N4M9 | Trypanosoma rangeli | 77% | 100% |
A4HDU9 | Leishmania braziliensis | 90% | 100% |
A4I144 | Leishmania infantum | 98% | 100% |
C9ZKU0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 100% |
O61219 | Caenorhabditis elegans | 30% | 100% |
O74457 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 44% | 100% |
P36416 | Dictyostelium discoideum | 28% | 100% |
P61599 | Homo sapiens | 52% | 100% |
P61600 | Mus musculus | 52% | 100% |
Q05885 | Leishmania donovani | 97% | 100% |
Q06504 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 40% | 100% |
Q2PFM2 | Macaca fascicularis | 52% | 100% |
Q3UX61 | Mus musculus | 30% | 100% |
Q4QA94 | Leishmania major | 86% | 100% |
Q4V8K3 | Rattus norvegicus | 30% | 97% |
Q58ED9 | Danio rerio | 52% | 100% |
Q6P632 | Xenopus tropicalis | 51% | 100% |
Q7ZXR3 | Xenopus laevis | 52% | 100% |
Q8LGI8 | Arabidopsis thaliana | 53% | 100% |
Q8SSN5 | Dictyostelium discoideum | 52% | 100% |
Q9BSU3 | Homo sapiens | 28% | 100% |
Q9FKI4 | Arabidopsis thaliana | 33% | 100% |
Q9QY36 | Mus musculus | 29% | 100% |
Q9UTI3 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 28% | 100% |